A High Concentration of Circulating Insulin Suppresses the Glucagon Response to Hypoglycemia in Normal Man*
Abstract
In an attempt to clarify whether circulating insulin per se exerts an inhibitory effect on the hormonal responses to hypoglycemia, with special emphasis on glucagon secretion, nine healthy volunteers were exposed to low dose (244 pmol/kg.h) and high dose (1034 pmol/kg.h) iv insulin infusions for 3 h on two separate occasions. A close to identical arterial hypoglycemia of about 3.4 mmo/L was obtained in both tests by glucose clamping during the high dose test. The corresponding glucose concentration in the venous blood was significantly lower in the high dose test (2.5 +/- 0.1 vs. 3.0 +/- 0.1 mmol/L; P less than 0.01), while the plasma free insulin level was 4 times higher in the high dose test (897 +/- 50 vs. 208 +/- 14 pmol/L). Plasma glucagon was elevated in both experiments, but its rise was reduced during the high dose test after 1 h, yielding an incremental area under the glucagon curve that was significantly smaller than that obtained during the low dose test (213 +/- 70 vs. 348 +/- 81 ng/L.h; P less than 0.05). The plasma adrenaline, noradrenaline, GH, C-peptide, pancreatic polypeptide, and somatostatin profiles were similar in the two tests. We conclude that an inhibitory effect of circulating insulin on the glucagon response to hypoglycemia can be demonstrated in normal man during an infusion of insulin yielding a plasma concentration of about 900 pmol/L. The responses of other hormones studied are not significantly influenced by the circulating insulin level.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the hypoglycaemic range, the arteriovenous difference is small (probably less than 0.2 mmol/l), but it can be influenced considerably by the level and duration of hyperinsulinaemia.
“In the hypoglycaemic range the arteriovenous difference is small (probably less than 0.2 mmol/l), but it can be influenced considerably by the level and duration of hyperinsulinaemia [8].”
From Defining hypoglycaemia: what level has clinical relevance? (2009) · cites this paper as [8]
Evidence exists in nondiabetic and type 1 diabetic subjects to implicate hyperinsulinemia per se in suppressing the release of glucagon in response to hypoglycemia while increasing catecholamine and cortisol release, although this has been disputed.
“Evidence exists in nondiabetic and type 1 diabetic subjects to implicate hyperinsulinemia per se in suppressing the release of glucagon in response to hypoglycemia (43-46) while increasing catecholamine and cortisol release (47), although this has been disputed (48).”
From Hypoglycemia in Type 2 Diabetes (2005) · cites this paper as [45]
The citation lists haven’t been fetched yet
References 34 · Cited by 76
- Authors
- LlU, D., MOBERG, E., KOLLIND, M., LINS, P.-E., & ADAMSON, U.
- Affiliations
- Danderyds sjukhus (SE)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1991-11
- Volume
- 73
- Issue
- 5
- Pages
- 1123-1128
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2058969843
- Semantic Scholar
- 3ac8f2f949b318c2b2094eb32002d58ae087f8f2
- Cited by
- 76
- References
- 34
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2021: 1 · 2020: 2 · 2017: 1 · 2015: 1 · 2013: 2 · 2012: 1
- FWCI
- 6.78
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- insulin, glucagon, hypoglycemia, insulin-glucagon interaction, insulin infusion, epinephrine, norepinephrine, growth hormone, C-peptide, pancreatic polypeptide, somatostatin
- MeSH terms
- Adult, Blood Glucose, C-Peptide, Epinephrine, Female, Glucagon, Humans, Hypoglycemia, Infusions, Intravenous, Insulin, Kinetics, Male, Norepinephrine, Pancreatic Polypeptide, Somatostatin, Growth Hormone, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review